OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

Name: OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression
Creator: 北京蛋白质组研究中心
Published: 2026-06-26T00:00:00+08:00

国家人口健康科学数据中心2026-07-02 收录

胰腺癌吉西他滨耐药

G2/M细胞周期调控

数据链接：

https://www.ncmi.cn/phda/dataDetails.do?id=CSTR:17970.11.A001G.202607.27.V1.0 数据链接链接失效反馈

官方服务：

资源简介：

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

提供机构：

北京蛋白质组研究中心

创建时间：

2026-06-26

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

资源简介：

相关数据集